Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
23andMe to cut 40% of workforce, end therapeutics program
Nov. 11 (UPI) --Genetic-testing lab
23andMe
plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the company announced Monday. The layoffs will impact about 200 employees at the California-based firm and are ...
23andMe cuts 40% of its workforce, discontinues all therapy programs
Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring program.
23andMe to slash 40% of its workforce, end therapeutics program to cut costs
DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as part of a restructuring effort to cut costs, the company said Monday.
23andMe to Cut Workforce by 40%, Discontinues Therapeutics Pipeline
23andMe
is further streamlining its operations as it discontinues its pipeline of cancer-related therapeutic programs while it evaluates alternatives for its clinical and preclinical assets. The South San Francisco, Calif.-based human genetics company on ...
23andMe to slash 40% of workforce as it restructures and shutters therapeutics division
Bay Area genetic testing company 23andMe announced Monday that it plans to lay off 40% of its workforce as part of a broader restructuring effort aimed at cutting costs and refocusing the company on its core business.
3h
DNA-testing site 23andMe to lay off 40% of its workers
The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.
FierceBiotech
7h
23andMe shutters cancer drug research programs, lays off 40% of staff
23andMe
is shutting down its therapeutics development division, and plans to seek out buyers to find a new home for its ...
1h
23andMe to reduce overall headcount by 40% of workforce
Holding “announced a business restructuring to streamline operations and reduce costs. In addition, 23andMe is discontinuing ...
STAT
1d
The end of 23andMe’s drug discovery dream
23andMe
, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business ...
13h
Federal law could prevent your 23andMe data deletion, but you should still try
Requesting deletion closes your account permanently and prevents your data from being used in further research (existing ...
6h
23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future
Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 millionDiscontinues development of therapeutics division and ...
CTV News
4h
23andMe cuts 40 per cent of its workforce, discontinues all therapy programs
Genetic testing firm
23andMe
said on Monday it is reducing about 40 per cent, or 200 employees, from its workforce and ...
Honolulu Star-Advertiser
1d
23andMe cuts 40% of its workforce, stops therapy programs
Genetic testing firm
23andMe
said today it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring program. ...
Yahoo Finance
4d
CORRECTION - 23andMe to Report Q2 FY2025 Financial Results
SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- An earlier release under the same headline should have noted
23andMe
...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback